A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...

As HIV/AIDS enters its fifth decade, Black women's leadership offers urgent lessons about public health, community care, and ...

Following in the footsteps of Gilead Sciences, Merck & Co. has signed voluntary licensing agreements to enable access to its ...

Lenacapavir is one injection, twice a year. It's a big improvement for people in high-risk groups, currently taking a pill a ...

People living with HIV need to take antiretroviral treatment for life to prevent the virus from multiplying in their body. But some people, known as 'post-treatment controllers,' have been able to ...

As people with HIV live longer, diabetes is becoming an increasingly important contributor to morbidity and mortality, ...

July 21 (Reuters) - Gilead Sciences and Merck said on Tuesday their experimental once-weekly HIV pill kept the virus ...

Doctors Without Borders (MSF) has called for a drastic reduction in the price of a key medication used to prevent HIV ...

Scientists have identified promising real-world links between common HIV drugs and a reduced incidence of Alzheimer's disease. Alzheimer's disease (AD) currently afflicts nearly seven million people ...

The incidence of skin diseases in people with HIV has declined significantly over the past decade, but some patient groups remain at a higher risk, particularly for cutaneous malignancies (CM), ...

The Aliveness Project — a south Minneapolis nonprofit that's provided HIV testing, prevention and support services for nearly four decades — says it's losing roughly $450,000 a year in direct federal ...

The Aliveness Project stated the CDC would not renew the grant that provides $450K annually.